Tamoxifen alone versus adjuvant tamoxifen for operable breast cancer of the elderly: Long-term results of the phase III randomized controlled multicenter GRETA trial

G. Mustacchi, R. Ceccherini, S. Milani, A. Pluchinotta, A. De Matteis, L. Maiorino, A. Farris, A. Scanni, F. Sasso, A. Bolognesi, E. Villa, S. Cobelli, C. Boni, A. Zadro, C. Cacioppo, P. Gambrosier, G. Schieppati, P. Sismondi, F. Genta, A. TrainaA. Malloci, M. Mansutti, Carla Dellach, V. Fosser, F. Schittulli

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Tamoxifen alone versus adjuvant tamoxifen for operable breast cancer of the elderly: Long-term results of the phase III randomized controlled multicenter GRETA trial'. Together they form a unique fingerprint.

Medicine & Life Sciences